Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research

References

• Akyol O, Herken H, Uz E, et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 995–1005
   PubMed Web of Science ®Google Scholar
• Arvindakshan M, Sitasawad S, Debsikdar V, et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 2003a; 53: 56–64
   PubMed Web of Science ®Google Scholar
• Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 2003b; 62: 195–204
   PubMed Web of Science ®Google Scholar
• Bindoli A, Rigobello MP, Cavallini L, Dalla LA, Galzigna L. Decrease of serum malondialdehyde in patients treated with chlorpromazine. Clin Chim Acta 1987; 169: 329–332
   PubMedGoogle Scholar
• Block G, Dietrich M, Norkus EP, et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002; 156: 274–285
   PubMed Web of Science ®Google Scholar
• Brown K, Reid A, White T, et al. Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia. Biol Psychiatry 1998; 43: 863–867
   PubMedGoogle Scholar
• Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A. Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 2004; 49: 205–209
   PubMed Web of Science ®Google Scholar
• Gama CS, Salvador M, Andreazza AC, Kapczinski F, Belmonte-de-Abreu P. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 512–515
   PubMed Web of Science ®Google Scholar
• Gawel S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek 2004; 57: 453–455
   PubMedGoogle Scholar
• Grignon S, Chianetta JM. Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 365–369
   PubMed Web of Science ®Google Scholar
• Guy, W. 1976. ECDEU assessment manual for psychopharmacology. Washington, DC: US Department of Health, Education, and Welfare publication (ADM), Goverment Printing Office.
   Google Scholar
• Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 1996; 16: 33–50
   PubMed Web of Science ®Google Scholar
• Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 2002; 58: 1–10
   PubMed Web of Science ®Google Scholar
• Kharb S, Ghalaut VS. Plasma lipoperoxides: a preliminary reference range. Indian J Med Sci 2003; 57: 105–107
   PubMedGoogle Scholar
• Kikugawa K, Kojima T, Yamaki S, Kosugi H. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Anal Biochem 1992; 202: 249–255
   PubMed Web of Science ®Google Scholar
• Knight JA, Smith SE, Kinder VE, Anstall HB. Reference intervals for plasma lipoperoxides: age-, sex-, and specimen-related variations. Clin Chem 1987; 33: 2289–2291
   PubMed Web of Science ®Google Scholar
• Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002; 20: 171–175
   PubMed Web of Science ®Google Scholar
• Mahadik SP, Mukherjee S, Scheffer R, Correnti EE, Mahadik JS. Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biol Psychiatry 1998; 43: 674–679
   PubMed Web of Science ®Google Scholar
• McCreadie RG, MacDonald E, Wiles D, Campbell G, Paterson JR. The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects. Br J Psychiatry 1995; 167: 610–617
   PubMed Web of Science ®Google Scholar
• Morera AL, Abreu P. Seasonality of psychopathology and circannual melatonin rhythm. J Pineal Res 2006; 41: 279–283
   PubMed Web of Science ®Google Scholar
• Morera AL, Abreu P. Daytime/night-time and summer/winter melatonin and malondialdehyde rhythms: an inverse relationship. J Pineal Res 2007; 43: 313–314
   PubMed Web of Science ®Google Scholar
• Ranjekar PK, Hinge A, Hegde MV, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003; 121: 109–122
   PubMed Web of Science ®Google Scholar
• Reddy RD, Yao JK. Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 1996; 55: 33–43
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Melchiorri D, Sewerynek E, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 1–11
   PubMed Web of Science ®Google Scholar
• Schmidt AJ, Krieg JC, Vedder H. Antioxidative and steroid systems in neurological and psychiatric disorders. World J Biol Psychiatry 2005; 6: 26–35
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(Suppl 20)22–33
   PubMed Web of Science ®Google Scholar
• SSRG. 2000. Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia. Scottish Schizophrenia Research Group. Br J Psychiatry, 176: 290–293.
   PubMedGoogle Scholar
• Tunez I, del Carmen MM, Feijoo M, Valdelvira ME, Munoz-Castaneda J, Montilla P. Melatonin effect on renal oxidative stress under constant light exposure. Cell Biochem Funct 2003; 21: 35–40
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Richter R. Seasonality in biochemical determinations: a source of variance and a clue to the temporal incidence of affective illness. Psychiatry Res 1979; 1: 53–60
   PubMed Web of Science ®Google Scholar
• Zhang, XY, Tan, YL, Cao, , et al. 2006. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res, 81: 291–300.
   PubMed Web of Science ®Google Scholar